130 related articles for article (PubMed ID: 33276119)
1. A 6-step rapid desensitization protocol to hydroxychloroquine.
Sutton KM; Fernando SL
Ann Allergy Asthma Immunol; 2021 Mar; 126(3):292-293. PubMed ID: 33276119
[No Abstract] [Full Text] [Related]
2. Hydroxychloroquine desensitization, an effective method to overcome hypersensitivity-a multicenter experience.
Tal Y; Maoz Segal R; Langevitz P; Kivity S; Darnizki Z; Agmon-Levin N
Lupus; 2018 Apr; 27(5):703-707. PubMed ID: 28992797
[TBL] [Abstract][Full Text] [Related]
3. Successful short desensitization for the eruption of hydroxychloroquine.
Hayami T; Tanaka T; Fujimoto N
Lupus; 2019 Jun; 28(7):918-919. PubMed ID: 31112453
[No Abstract] [Full Text] [Related]
4. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G
Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
[TBL] [Abstract][Full Text] [Related]
5. Delayed hypersensitivity skin reaction to hydroxychloroquine: Successful short desensitization.
Barailler H; Milpied B; Chauvel A; Claraz P; Taïeb A; Seneschal J; Darrigade AS
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):307-308. PubMed ID: 29800755
[No Abstract] [Full Text] [Related]
6. [The visual system in 30 subjects with discoid lupus erythematosus treated with hydroxychloroquine].
Rossi A; Rinaldi M; Vozza A; Romano A; Turco P
G Ital Dermatol Venereol; 1988 Apr; 123(4):189-92. PubMed ID: 3182010
[No Abstract] [Full Text] [Related]
7. The use of hydroxychloroquine in lupus pregnancy: the British experience.
Khamashta MA; Buchanan NM; Hughes GR
Lupus; 1996 Jun; 5 Suppl 1():S65-6. PubMed ID: 8803914
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases.
Buchanan NM; Toubi E; Khamashta MA; Lima F; Kerslake S; Hughes GR
Ann Rheum Dis; 1996 Jul; 55(7):486-8. PubMed ID: 8774170
[TBL] [Abstract][Full Text] [Related]
9. Immunofluorescent "band" test for lupus erythematosus. II. Employing skin lesions.
Burnham TK; Neblett TR; Fine G
Arch Dermatol; 1970 Jul; 102(1):42-50. PubMed ID: 4925010
[No Abstract] [Full Text] [Related]
10. Hydroxychloroquine-induced erythroderma.
Pai SB; Sudershan B; Kuruvilla M; Kamath A; Suresh PK
Indian J Pharmacol; 2017; 49(1):132-134. PubMed ID: 28458440
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy of lupus erythematosus].
Glavinskaia TA; Kurnikov GIu; Pavlova LT
Vestn Dermatol Venerol; 1982 Jul; (7):4-8. PubMed ID: 7136252
[No Abstract] [Full Text] [Related]
12. [Evaluation of the effectiveness of the imuran treatment of lupus erythematosus].
Krupko MI; Gorbunov VF; Domaseva TV
Vestn Dermatol Venerol; 1977 Feb; (2):59-62. PubMed ID: 324171
[No Abstract] [Full Text] [Related]
13. Ocular changes induced by long-term hydroxychloroquine (plaquenil) therapy.
Shearer RV; Dubois EL
Am J Ophthalmol; 1967 Aug; 64(2):245-52. PubMed ID: 6036279
[No Abstract] [Full Text] [Related]
14. Immunologic concepts of light reactions in lupus erythematosus and polymorphous light eruptions. I. The mechanism of action of hydroxychloroquine.
Lester RS; Burnham TK; Fine G; Murray K
Arch Dermatol; 1967 Jul; 96(1):1-10. PubMed ID: 5298279
[No Abstract] [Full Text] [Related]
15. Therapeutic efficacy and adverse events of hydroxychloroquine administration in Japanese systemic/cutaneous lupus erythematosus patients.
Kishi C; Motegi SI; Yasuda M; Ishikawa O
J Dermatol; 2018 Aug; 45(8):1020-1022. PubMed ID: 30133802
[No Abstract] [Full Text] [Related]
16. Type IV allergy to antimalarials can mimic cutaneous manifestations of lupus erythematosus.
Borik L; Petzelbauer P; Quint T; Wöhrl S; Kinaciyan T; Heil PM
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):e94-e96. PubMed ID: 30223310
[No Abstract] [Full Text] [Related]
17. [Study of T lymphocyte subpopulations in patients with lupus erythematosus using monoclonal antibodies during immunocorrective therapy].
Berenbeĭn BA; Kagramanov GV; Slavina EG
Vestn Dermatol Venerol; 1987; (3):10-3. PubMed ID: 3300088
[No Abstract] [Full Text] [Related]
18. Early cutaneous eruptions after oral hydroxychloroquine in a lupus erythematosus patient: A case report and review of the published work.
Matsuda T; Ly NTM; Kambe N; Nguyen CTH; Ueda-Hayakawa I; Son Y; Okamoto H
J Dermatol; 2018 Mar; 45(3):344-348. PubMed ID: 29239026
[TBL] [Abstract][Full Text] [Related]
19. Desensitization to hydroxychloroquine--experience of 4 patients.
Mates M; Zevin S; Breuer GS; Navon P; Nesher G
J Rheumatol; 2006 Apr; 33(4):814-6. PubMed ID: 16463436
[TBL] [Abstract][Full Text] [Related]
20. Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial.
Olsen NJ; James JA; Arriens C; Ishimori ML; Wallace DJ; Kamen DL; Chong BF; Liao D; Chinchilli VM; Karp DR
Trials; 2018 Dec; 19(1):694. PubMed ID: 30572906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
